We found a significantly larger difference (40%%) between the third (35 44) and fifth (55 65) age-bands suggesting that, although recovery could explain a significant part of the observed data, it is unlikely that it is the sole explanation.
For Infinium II probes, probes with SNPs with average heterozygosity between 0.2 and 0.3 and greater than 0.4 appeared to have a significantly larger difference in beta value, whereas those outside these ranges showed potential for providing a way to ignore these SNPs.
Performance on different targets exhibits significantly larger differences in performance than differences between descriptor sets; for example the RMSE difference between the HIV mutant modeled best and worst was 1.2 log units.
Consistent with the population findings, individual neurons had significantly larger differences in firing rate to the near boundary stimuli when in different categories compared to the same category both during the post-saccade (boostrap test, p < 0.04) and reward (p < 0.01) periods of the task.
In contrast to earlier studies, the results also indicate that increases in age result in significantly larger differences between ApoE ɛ4 carriers and ApoE non-ɛ4 carriers on measures of episodic memory and global cognitive ability.
It is concluded that equilibrium and rate-based approaches can lead to significantly larger differences in calculated concentrations profiles for RSPs than for non-reactive operations, so that the additional effort of more complex modeling may be justified.
However, repeated measurement was carried out upon significantly larger differences [ 46].
Furthermore, we found the RMQ to have significantly larger differences in SRMraw between "important improvement" and "no change" patients in all subpopulations (Table 4).
No significant differences were found along the longitudinal axis, except for the left parahippocampal gyrus in which the anterior parts showed significantly larger differences than the posterior parts when controls were compared to AD patients.
Finally, in Kenya, Tanzania, and Uganda, public facilities had significantly larger differences than non-public facilities in relative differences between six-month availability and current availability among the 32 medicines (Table 6).
In both the N = 20 and N = 50 datasets, higher minor allele frequencies and lower GenTrain scores were associated with larger differences between the empirical and estimated values, respectively (General linear model, P < 0.001, Table 1); however, in the N = 20 dataset, MSV-3 loci had a significantly larger differences in between the empirical and estimated allele frequencies (P = 7.51 × 10-4).
